STUDY OF THE FEASIBILITY OF EXPANDING THE RANGE OF MEDICINES BASED ON PARACETAMOL
DOI:
https://doi.org/10.11603/2312-0967.2023.3.13914Keywords:
analgesics and antipyretics, medicinal products, marketing analysis, assortment, tabletsAbstract
The aim of the work. To conduct an analysis of medicinal products registered on the pharmaceutical market of Ukraine, which contain paracetamol in their composition.
Materials and Methods. The work is based on information obtained from the "State Register of Medicinal Products of Ukraine" website. The obtained data were processed and systematized using statistical, logical and graphic methods.
Results and Discussion. The pharmaceutical market of Ukraine contains a significant number of medicines with paracetamol and domestic manufacturers represent about 1/3 of its range, at the same time, there is no production of the substance. Paracetamol is known all over the world and has a significant number of dosage forms to cover the greatest possibilities of use in mono or combined composition. So, for example, today the combined compositions of "cold medicine" have gained popularity. However, there are dosage forms that are produced only in monoforms, they include: solution for injections, oral solution, suppositories, almost all suspensions.
Conclusions. On the basis of the review of literary sources and the analysis of the pharmaceutical market, a conclusion was made about the relevance of developing a prolonged form of paracetamol due to the formation of a matrix, which became the basis for further pharmaco-technological research to find the optimal composition of tablets.
References
Zempsky W, Bell J, Mossali VM, Kachroo P, Siddiqui K. Common selfcare indications of pain medications in children. Paediatr Drugs. 2023;25(3): 321-41. DOI: 10.1007/s40272-023-00562-1.
Karłowicz-Bodalska K, Sauer N, Jonderko L, Wiela-Hojeńska A. Over the counter pain medications used by adults: a need for pharmacist intervention. Int J Environ Res Public Health. 2023;20(5): 4505. DOI: 10.3390/ijerph20054505.
FDA Drug Safety Communication: FDA has reviewed possible risks of pain medicine use during pregnancy. FDA official site. 2015 URL: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-has-reviewed-possible-risks-pain-medicine-use-during-pregnancy.
Moungmaithong S, Leung BW, Sahota DS, Wang CC, Leung TY, Poon LC. Assessment of embryo morphology following perinatal exposure to aspirin, ibuprofen and paracetamol using whole embryo culture system. J Matern Fetal Neonatal Med. 2022;35(25): 8786-93. DOI: 10.1080/14767058.2021.2005020.
Sjoukes A, Venekamp RP, van de Pol AC, Hay AD, Little P, Schilder AG, Damoiseaux RA. Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children. Cochrane Database Syst Rev. 2016;12(12): CD011534. DOI: 10.1002/14651858.CD011534.pub2.
Abbasi M, Teakell J. Literature review: are NSAIDs harmful and is acetaminophen well tolerated? Curr Opin Nephrol Hypertens. 2023;32(3): 284-9. DOI: 10.1097/MNH.0000000000000886.
State Register of Medicinal Products of Ukraine. Available from: http://www.drlz.com.ua/ibp/ddsite.nsf/all/shlist?opendocument& sklad=%EF%E0%F0%E0%F6%E5%F2%E0%EC%EE%EB
Compendium of medicines. Available from: https://compendium.com.ua/uk/akt/80/2903/paracetamolum/
Darandale AS, Ghule PJ, Aher AA, Narwate BM. Sustained release dosage form: a concise review. International Journal of Pharmaceutics & Drug Analysis. 2017;5(5): 153-160.
Vekatashwaramoorthy N, Sambathkumar R, Subramani M. A novel approach on role of polymers used in sustained release drug delivery system – a review. Saudi Journal of Medical & Pharm. Sciences. 2021;7(4): 170-8. DOI: 10.36348/sjmps.2021.v07i04.002
Tawakkul N, Batool M, Batool S, Mustafa G, Faizan Nazar M. General mechanisms of drug loading and sustained release 4. Novel Platforms for Drug Delivery Applications. 2023;3: 31-57. DOI: 10.1016/B978-0-323-91376-8.00003-3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pharmaceutical Review / Farmacevtičnij časopis
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
